COMMONWEALTH EQUITY SERVICES, LLC - QUALIGEN THERAPEUTICS INC ownership

QUALIGEN THERAPEUTICS INC's ticker is QLGN and the CUSIP is 74754R103. A total of 31 filers reported holding QUALIGEN THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of QUALIGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2022$24,000
-51.0%
90,510
+3.4%
0.00%
Q2 2022$49,000
-14.0%
87,5100.0%0.00%
Q1 2022$57,000
-38.7%
87,5100.0%0.00%
Q4 2021$93,000
-47.8%
87,510
-36.4%
0.00%
Q3 2021$178,000
-34.8%
137,5100.0%0.00%
-100.0%
Q2 2021$273,000
-18.3%
137,510
+10.9%
0.00%0.0%
Q1 2021$334,000
+642.2%
124,049
+716.3%
0.00%
Q4 2020$45,00015,1970.00%
Other shareholders
QUALIGEN THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
HighMark Wealth Management LLC 80,094$104,0000.08%
PERKINS CAPITAL MANAGEMENT INC 51,178$67,0000.04%
HATTON CONSULTING, INC. 27,195$35,0000.03%
GSA CAPITAL PARTNERS LLP 78,687$102,0000.01%
CRA Financial Services, LLC 19,957$26,0000.01%
Virtu Financial LLC 25,507$33,0000.00%
WEDBUSH SECURITIES INC 32,228$42,0000.00%
TWO SIGMA SECURITIES, LLC 15,347$20,0000.00%
UBS Group AG 13,118$17,0000.00%
US BANCORP \DE\ 9,047$12,0000.00%
View complete list of QUALIGEN THERAPEUTICS INC shareholders